Researcher Image
رشا طالب عبدالله عجلان - Asst. Prof. Dr. Rasha Al- Sahlanee
PhD - assistant professor
College of Science , Department of Biotechnology
[email protected]
Summary

Rasha Al Sahlanee , I was born in Sept. 1979. I finished my BSc. in Microbiology in 2001 , employed in Biotechnology Dept. / science college of Baghdad university. in 2008 I got my MSc degree in Biotechnology from the same department. in 2011 I got a scholarship to peruse my PhD in Cote D'Azure unversity Nice -France in molecular and cellular interactions and I got it in 15 November 2016. I returned to Baghdad and continued my work as a lecturer in Immunology and animal tissue culture in Biotechnology dept. of the college of Science in the university of Baghdad. my research interests in immunotherapy and cancer research

Qualifications
  1. PhD in molecular and cellular interactions - Cote D'Azur University - Nice - France
  2. Msc. in Biotechnology - College of Science - University of Baghdad - Iraq
  3. Bsc. in Microbiology - College of Science - University of Baghdad - Iraq
Responsibility
  1. Director of accreditation unit. in College of Science - Univesity of Baghdad 2022-2023. Department Coordinator of Biotechnology Dept. -College of Science - Univesity of Baghdad 2019-2021. Department Coordinator of Biotechnology Dept. - College of Science - Univesity of Baghdad
Awards and Memberships
  1. Editor in American Journal of Biomedical and Life Sciences (AJBLS)
  2. Vice President in Iraqi- French Cultural xchange Organization.
    2021 -2022. member in Science and Knowledge Association
  3. member in Iraqi Biological Society.
Research Interests

Animal tissue culture techniques. Immunology - cancer research- molecular - nanotechnology and biomaterials

Academic Area

Biotechnology and Biology

Teaching

2017- till now - Animal Tissue Culture for Fourth Stage 2018. Histology and Micropreparation for Second stage 2019 - 2022 . Microbiology for Second stage

Supervision

2017- till now . Undergraduate graduation Projects 2022. supervised on Master thesis "Molecular and Immunological Study of Myeloid Related Protein (MRP14) and Chemokine (CXCL9) in a Sample of Iraqi Patients with Thyroid Diseases " 2022. Study of antineoplastic activity of Escherichia coli locsupervisor of Msc. thesis al isolates outer membrane Nano vesicle.

Publication Date
Wed Jan 01 2020
Journal Name
International Conference Of Numerical Analysis And Applied Mathematics Icnaam 2019
Isolation and characterization study towards microbial improved oil recovery applications
...Show More Authors

View Publication
Scopus Clarivate Crossref
Publication Date
Thu Sep 01 2016
Journal Name
Archives Of Toxicology
Effect of natural uranium on the UMR-106 osteoblastic cell line: impairment of the autophagic process as an underlying mechanism of uranium toxicity
...Show More Authors

View Publication
Scopus (35)
Crossref (29)
Scopus Clarivate Crossref
Publication Date
Thu Jan 04 2018
Journal Name
International Journal Of Molecular Sciences
Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
...Show More Authors

View Publication
Scopus (39)
Crossref (30)
Scopus Clarivate Crossref
Publication Date
Thu Dec 29 2022
SEROLOGICAL AND MOLECULAR EVALUATION OF MRP14 IN THYROIDITIS AND ITS ROLE IN PRO-INFLAMMATORY CHEMOKINES ACTIVATION
...Show More Authors

This study was aimed to investigate the involvement of Myeloid Related Protein 14 (MRP14) in the production of CXC Motif Chemokine Ligand 9 (CXCL9) in thyroiditis patients. The first group composed of 27 hypothyroidism (HO) patients (12 men and 15 women), age average about 46 years old. The second group had 43 patients (8 men and 35 women) with hyperthyroidism (HR), their mean of age was 42, while 30 healthy persons act as control group (HC) had an average age of 33.47 of men (13) and women (17). The three groups were testing for triiodothyronine (T3), thyroxine (T4) and thyroid stimulating hormone (TSH) furthermore, testing the thyroglobulin (TG), anti-thyroperoxidase (a-TPO), anti-TSH receptor (TSHR) and serum level of MRP14 by

... Show More
View Publication Preview PDF
Scopus (4)
Scopus Crossref
Publication Date
Fri Sep 15 2023
Journal Name
Sumer 2
Predictive value of C-reactive protein, D-dimer, Hemoglobin and Lactate dehydrogenase levels in diagnosing COVID-19 patients
...Show More Authors

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused enormous issues worldwide and is the most infectious pandemic. This study included 50 subjects (evenly distributed between sexes) and their range of ages starting from 2 to 67 years. According to the study's result, the ages and genders of subjects include susceptibility to COVID-19. Males were found to be more infected than females, and the ages of 36 to 67 were more common than other age ranges. Also, BMI calculations revealed that male patients with COVID-19 have the highest percentage of obesity. The clinical parameter results have been found serum C‐reactive protein (CRP) as an essential indicator that changes significantly in infection with COVID‐19 an

... Show More
View Publication
Crossref (1)
Scopus Crossref
Publication Date
Sun Nov 02 2014
Journal Name
Autophagy
Autophagy in osteoblasts is involved in mineralization and bone homeostasis
...Show More Authors

View Publication
Scopus (356)
Crossref (338)
Scopus Clarivate Crossref
Publication Date
Sun Oct 15 2023
Journal Name
Sumer 4
CYTOTOXIC IMPACT OF OUTER MEMBRANE NANOVESICLES (OMVS) ON OVARIAN CANCER
...Show More Authors

This study focused on extracting the outer membrane nanovesicles (OMVs) from Escherichia coli BE2 (EC- OMVs) by ultracentrifugation, and the yield was 2.3mg/ml. This was followed by purification with gel filtration chromatography using Sephadex G-150, which was 2mg/ml. The morphology and size of purified EC-OMVs were confirmed by transmission electron microscopy (TEM) at 40-200 nm. The nature of functional groups in the vesicle vesicle was determined by Fourier transforms infrared spectroscopy (FT-IR) analysis. The antitumor activity of EC-OMVs was conducted in vitro by MTT assay in human ovarian (OV33) cancer cell line at 24,48 and 96hrs. The cytotoxicity test showed high susceptibility to the vesicles in ovarian compared to normal

... Show More
View Publication
Scopus (1)
Crossref (1)
Scopus Crossref
Publication Date
Thu Apr 27 2023
Journal Name
Medical Journal Of Babylon
Histological Changes in Liver and Cardiac Rat Tissues after Exposure to Chitosan Nanoparticles Orally
...Show More Authors

Scopus (4)
Scopus
Publication Date
Thu Dec 01 2022
Journal Name
Advances In Cancer Biology - Metastasis
CX3CL1 as potential immunotherapeutic tool for bone metastases in lung cancer: A preclinical study
...Show More Authors

View Publication
Scopus (1)
Crossref (1)
Scopus Clarivate Crossref
Publication Date
Sun Oct 30 2022
Anticancer Mechanisms of Zoledronic Acid-Based Graphene Oxide Nanoparticles for Prostate Cancer Bone Metastases Treatment
...Show More Authors

     Bone metastases are the main reason for death in males suffering from advanced prostate cancer. This study aimed to create zoledronic acid and graphene oxide conjugation for anticancer therapy. The process of conjugation was confirmed by several characterization methods including UV-VIS spectrophotometry, Fourier Transform Infrared Spectroscopy (FTIR), and atomic force microscope (AFM). the cytotoxicity of 400, 600, and 800 μg/ml to each GO, ZOL, and ZOL-GO was evaluated on a human hepatic cell line (WRL 68) and human prostate cancer cell line (PC3) using an MTT assay. The antitumor mechanisms of ZOL-GO were examined by cell cycle analysis. The results demonstrated That ZOL-GO caused a reduction in the cell viability of WRL 68

... Show More
View Publication Preview PDF
Scopus (6)
Crossref (2)
Scopus Crossref
Publication Date
Sat Jun 08 2024
Journal Name
Karbala International Journal Of Modern Science
Designing of Human Serum Albumin Nanoparticles for Drug Delivery: a Potential Use of Anticancer Treatment
...Show More Authors

Human serum albumin (HSA) nanoparticles have been widely used as versatile drug delivery systems for improving the efficiency and pharmaceutical properties of drugs. The present study aimed to design HSA nanoparticle encapsulated with the hydrophobic anticancer pyridine derivative (2-((2-([1,1'-biphenyl]-4-yl)imidazo[1,2-a]pyrimidin-3-yl)methylene)hydrazine-1-carbothioamide (BIPHC)). The synthesis of HSA-BIPHC nanoparticles was achieved using a desolvation process. Atomic force microscopy (AFM) analysis showed the average size of HSA-BIPHC nanoparticles was 80.21 nm. The percentages of entrapment efficacy, loading capacity and production yield were 98.11%, 9.77% and 91.29%, respectively. An In vitro release study revealed that HSA-BIPHC nan

... Show More
View Publication Preview PDF
Scopus (1)
Crossref (1)
Scopus Crossref
Publication Date
Mon Dec 30 2024
Wound healing and the antimicrobial impact by using biosynthesized iron oxide nanoparticles
...Show More Authors

   Chronic wound infections are a major cause of chronic wound development. This study aimed to investigate the role of Fe2O3 nanoparticles (Fe2O3 NPs) in the growth inhibition of multidrug resistant bacteria (MDR) and enhancement of human foreskin cell line migration and proliferation. For this aim, Fe2O3 NPs were synthesized from the bacterial extract and characterized it with UV-Vis, EDS, FTIR, AFM and FESEM assays. In addition, investigate the antibacterial effect using the well diffusion method. as well as study the cytotoxicity effect via MTT assay and the migration of cells through the scratch wound assay for human foreskin (HFF) cell line. The results confirmed t

... Show More
View Publication Preview PDF
No Events Found